Oncogene-driven genomic profiles are linked to poor overall survival in muscle-invasive bladder cancer (MIBC)
It is suggested that oncogene amplifications, rather than traditional genomic instability metrics, are associated with poor overall survival in MIBC, warranting validation in larger cohorts to assess their potential relevance as prognostic markers and therapeutic targets.